DrugPatentWatch Database Preview
Cspc Ouyi Company Profile
» See Plans and Pricing
What is the competitive landscape for CSPC OUYI, and what generic and branded alternatives to CSPC OUYI drugs are available?
CSPC OUYI has fifteen approved drugs.
Summary for Cspc Ouyi
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 15 |
Drugs and US Patents for Cspc Ouyi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cspc Ouyi | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 078321-002 | Apr 17, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cspc Ouyi | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 211310-002 | Oct 16, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cspc Ouyi | CELECOXIB | celecoxib | CAPSULE;ORAL | 210071-001 | Jan 23, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cspc Ouyi | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 209527-002 | May 7, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cspc Ouyi | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765-002 | Aug 25, 2017 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Cspc Ouyi | CELECOXIB | celecoxib | CAPSULE;ORAL | 210071-002 | Jan 23, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
